galactosamine has been researched along with linarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HI; Kim, JS; Kim, SJ; Kim, YH; Kwak, JH; Lee, SK; Lee, SM; Park, JH | 1 |
| Feng, X; Guang, C; Li, Y; Qiu, F; Zhao, N | 1 |
2 other study(ies) available for galactosamine and linarin
| Article | Year |
|---|---|
Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
Topics: Alanine Transaminase; Animals; Apoptosis; Apoptosis Regulatory Proteins; Aspartate Aminotransferases; Bcl-2-Like Protein 11; bcl-X Protein; Caspase 3; Caspase 8; Cytochromes c; Cytoprotection; Cytosol; Fas-Associated Death Domain Protein; Galactosamine; Glycosides; Interferon-gamma; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Membrane Proteins; Mice; Phosphorylation; Proteolysis; Proto-Oncogene Proteins; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
LC-MS/MS Method for Simultaneous Determination of Linarin and Its Metabolites in Rat Plasma and Liver Tissue Samples: Application to Pharmacokinetic and Liver Tissue Distribution Study After Oral Administration of Linarin.
Topics: Administration, Oral; Animals; Chemical and Drug Induced Liver Injury; Chromatography, Liquid; Disease Models, Animal; Galactosamine; Glycosides; Liver; Male; Plasma; Rats; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tissue Distribution | 2019 |